ELDN- Eledon Pharmaceuticals, Inc.

Name: Eledon Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Eledon Pharmaceuticals, Inc. (ELDN) has 6 insiders with recent SEC Form 4 filings, including 18 buys and 3 sells. ELDN is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Robinson James A. Jr.	3.4K	$13.2K	-
Dir	Lee June	3.4K	$13.2K	-
Dir	Kirk Allan	3.4K	$13.2K	-
Dir	Hillson Jan	3.4K	$13.2K	-
Dir	McBride John S.	3.4K	$13.2K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 9, 2024	Bvf Partners L P/il60	10% Owner	Buy	1,927,937	$0.00	-	+45.0%	+8.3%	+20.4%
May 5, 2023	Bvf Partners L P/il60	10% Owner	Buy	1,978,932	$0.00	-	+85.7%	-51.5%	-10.1%
Nov 23, 2022	Perrin Steven	President	Buy	1,000	$2.60	$2,596.90	New	-4.4%	-53.0%
Dec 20, 2021	Gros David-Alexandre C	Chief Executive Officer	Buy	2,000	$4.48	$8,960.00	+28.6%	-22.9%	-46.5%
Aug 17, 2021	Gros David-Alexandre C	Chief Executive Officer	Buy	4,000	$6.21	$24,840.00	+133.3%	-13.1%	-47.7%
Jun 11, 2021	Little Paul Sean	Chief Financial Officer	Buy	10,000	$8.87	$88,700.00	New	-10.9%	-56.8%
Jun 9, 2021	Gros David-Alexandre C	Chief Executive Officer	Buy	3,000	$8.01	$24,030.00	New	-0.7%	-58.1%
Dec 2, 2020	Orbimed Israel GP Ltd.	10% Owner	Sell	103,200	$21.60	$2,229,120.00	-58.4%	-	-
Oct 30, 2020	Logos Global Management LP	10% Owner	Sell	12,969	$26.64	$345,558.78	-3.2%	-	-
Oct 30, 2020	Logos Global Management LP	10% Owner	Buy	92,040	$25.44	$2,341,713.69	+7.3%	-	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC